Close-up of a hand gently touching a grapefruit against an orange background, showcasing freshness and elegance.

Vulval Intra-epithelial Neoplasia (VIN)

Vulval Intra-epithelial Neoplasia (VIN) refers to abnormal cell changes in the skin of the vulva (the external genital area, including the labia, clitoris, and vaginal opening). These changes are not cancer, but in rare cases, they may develop into vulval cancer if left untreated. VIN is graded as:

  • VIN1 (low-grade): Mild changes unlikely to progress.
  • VIN2/3 (high-grade): More severe changes with a higher risk of becoming cancerous.

Causes & Risk Factors

  • HPV infection: Most high-grade VIN is linked to human papillomavirus (HPV), especially types 16 and 18.
  • Non-HPV causes: Chronic skin conditions (e.g., lichen sclerosus) or immune system disorders.
  • Other risks: Smoking, older age, or a weakened immune system (e.g., due to HIV or chemotherapy).

Symptoms

  • Many women have no symptoms.
  • Possible signs include:
    • Persistent itching, burning, or pain in the vulva.
    • Thickened, raised, or rough skin patches.
    • Changes in skin colour (red, white, or dark patches).
    • Pain during sex or urination.
    • Wart-like growths (if HPV-related).

Diagnosis

  1. Vulval examination: For visible skin changes.
  2. Biopsy: A small skin sample is taken (under local anaesthetic) to confirm VIN and its grade.
  3. HPV testing: May be done alongside the biopsy.

Treatment Options

  • VIN1 (low-grade):
    • Often monitored without treatment, as it may resolve on its own.
    • Regular check-ups to track changes.
  • VIN2/3 (high-grade):
    • Topical treatments: Creams like imiquimod to boost the immune system.
    • Surgery: Removal of abnormal tissue (excision or laser therapy).

Self-Care

  • Keep the vulva clean and dry.
    • Use mild, fragrance-free soap and pat dry gently.
    • Take pain relief (e.g., paracetamol) as advised.

Possible Complications

  • Recurrence: Abnormal cells may return, requiring repeat treatment.
  • Infection or scarring (rare after surgery).
  • Psychological impact: Anxiety about cancer risk or body image changes.

Follow-Up Care

  • Regular vulval exams (every 6–12 months) to monitor for recurrence.
  • Continue cervical screening (if applicable), as HPV-linked VIN may coexist with cervical changes.

Prevention

  • HPV vaccination: Reduces risk of HPV-related VIN (available for ages 9–45).
  • Stop smoking: Smoking weakens immunity and increases cancer risk.
  • Manage skin conditions: Treat lichen sclerosus or other vulval conditions promptly.
  • Safe sex: Condoms reduce HPV transmission (but do not eliminate risk).

eGynaecologist Advice:

  • Mild symptoms of pain and light bleeding after surgical treatment for VIN may be normal however, you should consult your gynaecologist if you develop severe pain, heavy bleeding, or signs of infection (fever, pus, swelling).
  • You should seek gynaecological consultation if develop new or worsening symptoms (e.g., persistent itching, skin changes) when you are known to have VIN.